Antiretroviral therapy coverage in North Macedonia

North Macedonia: Antiretroviral therapy coverage was 59.0% in 2024. ◆ Volatile

Latest (2024)
59.0%
Change on year
up 5.4%
World rank
109th
of 143 countries
All-time high
59.0%
in 2024
All-time low
3.0%
in 2004
Years of data
25
2000–2024

Antiretroviral therapy coverage in North Macedonia, 2000–2024

02040602000201220242000: 7 % of people living with HIV2001: 8 % of people living with HIV2002: 8 % of people living with HIV2003: 9 % of people living with HIV2004: 3 % of people living with HIV2005: 9 % of people living with HIV2006: 13 % of people living with HIV2007: 16 % of people living with HIV2008: 20 % of people living with HIV2009: 18 % of people living with HIV2010: 22 % of people living with HIV2011: 23 % of people living with HIV2012: 26 % of people living with HIV2013: 28 % of people living with HIV2014: 30 % of people living with HIV2015: 37 % of people living with HIV2016: 41 % of people living with HIV2017: 44 % of people living with HIV2018: 48 % of people living with HIV2019: 49 % of people living with HIV2020: 53 % of people living with HIV2021: 52 % of people living with HIV2022: 53 % of people living with HIV2023: 56 % of people living with HIV2024: 59 % of people living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.

Analysis

North Macedonia recorded 59.0% for antiretroviral therapy coverage in 2024. That is the highest value across all 25 years on record.

The figure is up 5.4% on the previous year and up 96.7% over ten years.

Over the whole period, antiretroviral therapy coverage in North Macedonia peaked at 59.0% in 2024 and was at its lowest, 3.0%, in 2004.

That places North Macedonia 109th out of 143 countries with data for 2024, putting it in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage in North Macedonia, year by year

Annual values for Antiretroviral therapy coverage (% of people living with HIV) in North Macedonia, 2000 to 2024.
Year % of people living with HIV Change
2000 7.0%
2001 8.0% +14.3%
2002 8.0% +0.0%
2003 9.0% +12.5%
2004 3.0% -66.7%
2005 9.0% +200.0%
2006 13.0% +44.4%
2007 16.0% +23.1%
2008 20.0% +25.0%
2009 18.0% -10.0%
2010 22.0% +22.2%
2011 23.0% +4.5%
2012 26.0% +13.0%
2013 28.0% +7.7%
2014 30.0% +7.1%
2015 37.0% +23.3%
2016 41.0% +10.8%
2017 44.0% +7.3%
2018 48.0% +9.1%
2019 49.0% +2.1%
2020 53.0% +8.2%
2021 52.0% -1.9%
2022 53.0% +1.9%
2023 56.0% +5.7%
2024 59.0% +5.4%

North Macedonia compared with similar countries

  • North Macedonia's 59.0% is below the median for upper middle income countries, which is 65.5%, 90% of the median. (40 countries reporting)
  • North Macedonia's 59.0% is below the median for Europe & Central Asia, which is 83.0%, 71% of the median. (34 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage in North Macedonia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2005 +200.0% 3.0% 9.0%
2004 -66.7% 9.0% 3.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 11.1% 3.0% 20.0% 10
2010s 34.8% 22.0% 49.0% 10
2020s 54.6% 52.0% 59.0% 5

Countries ranked near North Macedonia

  1. 106 Barbados 60.0% compare
  2. 106 Bolivia, Plurinational State of 60.0% compare
  3. 106 Malaysia 60.0% compare
  4. 110 Paraguay 58.0% compare
  5. 111 Venezuela, Bolivarian Republic of 57.0% compare
  6. 112 Bahrain 55.0% compare
  7. 112 Syrian Arab Republic 55.0% compare

See the full ranking of 166 places →

More health data for North Macedonia

All data for North Macedonia →

Frequently asked questions

What is antiretroviral therapy coverage in North Macedonia?
Antiretroviral therapy coverage in North Macedonia was 59.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage recorded in North Macedonia?
The highest recorded value was 59.0% in 2024.
What is the lowest antiretroviral therapy coverage recorded in North Macedonia?
The lowest recorded value was 3.0% in 2004.
How does North Macedonia rank for antiretroviral therapy coverage?
North Macedonia ranks 109th out of 143 countries with data for 2024.
Is antiretroviral therapy coverage rising or falling in North Macedonia?
Over the last ten years it is up 96.7%. The long-run trend across the full record is volatile.
Where does this North Macedonia data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage in North Macedonia. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 13 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/north-macedonia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/north-macedonia/">Antiretroviral therapy coverage in North Macedonia</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage (% of people living with HIV)
Unit
% of people living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
166 places, 4,061 data points, 2000–2024
Last refreshed

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.